000			02067 a2200577 4500
005			20250515175316.0
264		0	_c20100917
008			201009s 0 0 eng d
022			_a1524-4733
024	7		_a10.1111/j.1524-4733.2009.00568.x _2doi
040			_aNLM _beng _cNLM
100	1		_aStevenson, Matt D
245	0	0	_aThe cost-effectiveness of bosentan in the United Kingdom for patients with pulmonary arterial hypertension of WHO functional class III. _h[electronic resource]
260			_bValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research _c
300			_a1100-5 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntihypertensive Agents _xeconomics
650	0	4	_aBosentan
650	0	4	_aChild
650	0	4	_aConfidence Intervals
650	0	4	_aConnective Tissue Diseases _xcomplications
650	0	4	_aCost-Benefit Analysis
650	0	4	_aDisease Progression
650	0	4	_aEpoprostenol _xeconomics
650	0	4	_aFemale
650	0	4	_aHealth Care Costs
650	0	4	_aHealth Expenditures
650	0	4	_aHumans
650	0	4	_aHypertension, Pulmonary _xcomplications
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aModels, Economic
650	0	4	_aPalliative Care _xeconomics
650	0	4	_aQuality of Life
650	0	4	_aQuality-Adjusted Life Years
650	0	4	_aSulfonamides _xeconomics
650	0	4	_aUnited Kingdom
650	0	4	_aWorld Health Organization
650	0	4	_aYoung Adult
700	1		_aMacdonald, Frances C
700	1		_aLangley, Jonathan
700	1		_aHunsche, Elke
700	1		_aAkehurst, Ron
773	0		_tValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research _gvol. 12 _gno. 8 _gp. 1100-5
856	4	0	_uhttps://doi.org/10.1111/j.1524-4733.2009.00568.x _zAvailable from publisher's website
999			_c18975597 _d18975597